Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lisa Torp"'
Publikováno v:
BMC Women's Health, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Purpose The survival rate amongst breast cancer survivors (BCS) have been increasing, with a 5-year survival rate of almost 90%. These women face many quality of life (QOL) issues either due to either cancer itself or the complex treatment r
Externí odkaz:
https://doaj.org/article/2df87cb79cb34498b1ece1561f16e16d
Autor:
Kit Yu Lu, Meagan Smith, Jennifer Lapse, Lisa Torp, Haleigh Minor, Latesha Blair, Julia Verbiar
Publikováno v:
Cancer Research. 80:P6-08
Introduction: The introduction of multi-gene testing for hereditary forms of breast cancer has changed the clinical approach to genetic testing for breast cancer patients. Recent consensus guideline now recommends genetic testing for all patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4d601d1aab4817d426bcbdbe0708bb2
https://doi.org/10.1158/1538-7445.sabcs19-p6-08-32
https://doi.org/10.1158/1538-7445.sabcs19-p6-08-32
Publikováno v:
Journal of Clinical Oncology. 40:e24064-e24064
e24064 Background: Long-term survival is common after breast cancer treatment with 5-year survival reaching almost 90%. Breast cancer survivors (BCS) face varying degrees of quality of life (QOL) issues depending on their age of diagnosis, disease se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::627a5391ea739ed295e7898e472f9e01
https://doi.org/10.1200/jco.2022.40.16_suppl.e24064
https://doi.org/10.1200/jco.2022.40.16_suppl.e24064
Autor:
Tejaswi Kanderi, Kit Lu, Lisa Torp, Julia Verbiar, Jennifer Laspe, Meagan Smith, Latesha Bair
Publikováno v:
Cureus
Background Breast cancer is the second leading cause of cancer death in women. There are multiple pathogenic mutations in addition to BRCA1/2 that are implicated in causing hereditary breast cancer. Methods and results We conducted a retrospective an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::825ab9017fadfbabc28e55c06256ff61
https://doi.org/10.7759/cureus.14637
https://doi.org/10.7759/cureus.14637
Autor:
Naomi Wiens, Brynn Wolff, Joella Wilson-Dagar, Yijin Wert, David Weksberg, Lisa Torp, Katherine Barton
Publikováno v:
Journal of Radiation Oncology. 7:175-179
BioZorb® is a tumor bed marker placed during partial mastectomy for targeted post-operative radiation. This study was designed to evaluate BioZorb® effect on radiation boost clinical target volume (CTV), planning target volume (PTV), median dose to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e6abaa458895f6ffd779f2e67e033a9
https://doi.org/10.1007/s13566-017-0339-y
https://doi.org/10.1007/s13566-017-0339-y
Publikováno v:
Journal of Clinical Oncology. 36:176-176
176 Background: Long term survival is common after breast cancer treatment with 5-year survival rate reaching almost 90%. Many breast cancer survivors (BCS) face varying degrees of quality of life (QOL) issues depending on their age of diagnosis, sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7de468ae44d8e52ddfac1d8c523d264
https://doi.org/10.1200/jco.2018.36.7_suppl.176
https://doi.org/10.1200/jco.2018.36.7_suppl.176
Publikováno v:
Journal of Clinical Oncology. 36:65-65
65 Background: Survivorship care is now being increasingly recognized as an important part of cancer care. The Commission on Cancer (CoC) Standard 3.3 now recommends 100% compliance in the delivery of Survivorship Care Plans (SCP) by 2019 to eligible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b441811f4328c411d61d1daa4f12695
https://doi.org/10.1200/jco.2018.36.7_suppl.65
https://doi.org/10.1200/jco.2018.36.7_suppl.65
Publikováno v:
Journal of Clinical Oncology. 36:17-17
17 Background: Survivors of breast cancer can face a multitude of long term and late effects after completing active treatment. Recommendations for side effect management can vary widely based on professional society guidelines, a provider’s clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7437d69da34cb84ca3f1e5a4166fa69d
https://doi.org/10.1200/jco.2018.36.7_suppl.17
https://doi.org/10.1200/jco.2018.36.7_suppl.17